| Literature DB >> 26066769 |
Hidetaka Akita1, Dai Kurihara2, Marco Schmeer3, Martin Schleef4, Hideyoshi Harashima5.
Abstract
The nuclear transfer process is one of the critical rate-limiting processes in transgene expression. In the present study, we report on the effect of compaction and the size of the DNA molecule on nuclear transfer efficiency by microinjection. A DNA/protamine complex- or variously-sized naked DNA molecules were injected into the cytoplasm or nucleus of synchronized HeLa cells. To evaluate the nuclear transfer process, a nuclear transfer score (NT score), calculated based on transgene expression after cytoplasmic microinjection divided by that after nuclear microinjection, was employed. The compaction of DNA with protamine decreased the NT score in comparison with the injection of naked DNA when the N/P ratio was increased to >2.0. Moreover, when naked DNA was microinjected, gene expression increased in parallel with the size of the DNA in the following order: minicircle DNA (MC07.CMV-EGFP; 2257 bp) > middle-sized plasmid DNA (pBS-EGFP; 3992 bp) > conventional plasmid DNA (pcDNA3.1-EGFP; 6172 bp), while the level of gene expression was quite comparable among them when the DNAs were injected into the nucleus. The above findings suggest that the intrinsic size of the DNA molecule is a major determinant for nuclear entry and that minicircle DNA has a great advantage in nuclear transfer.Entities:
Keywords: DNA; microinjection; nuclear transfer; size
Year: 2015 PMID: 26066769 PMCID: PMC4491651 DOI: 10.3390/pharmaceutics7020064
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Figure 1Synchronization of HeLa cells by hydroxyurea. Cell growth (A) and cell death (B) was monitored by counting the number of HeLa cells. The cells were cultured in the presence (closed) or absence (open) of 2.5 mM of hydroxyurea. The number of dead cells was counted by staining the cells with trypan blue. Gene expression of the EGFP after the microinjection of MC07.CMV-EGFP in the nucleus (C) or cytoplasm (D) of the non-treated cells (open) or synchronized cells (closed). Data are represented as the mean ± S.D. of triplicate experiments. The statistical differences were determined by the one-way ANOVA followed by Student’s t-test (**, p < 0.01). E(nuc), transgene expression after nuclear microinjection; E(cyt), transgene expression after cytoplasmic microinjection.
Sizes of protamine/DNA complexes.
| N/P Ratio | Diameter (nm) |
|---|---|
| 0.5 | 102 ± 2 |
| 2 | 83.6 ± 12.5 |
| 10 | 72.9 ± 7.9 |
Figure 2EGFP expression after the cytoplasmic and nuclear microinjection of protamine/DNA complexes. The minicircle DNA (MC07.CMV-EGFP) was compacted with protamine at N/P ratio of 0.5, 2 and 9. One thousand copies and 10 copies of DNA were injected into the cytoplasm (A) and the nucleus (B) with 0.5% RhoDex, respectively. At 24 h post injection, the ratio of GFP-positive cells to RhoDex-positive cells was calculated. (C) The nuclear transfer (NT) scores were calculated as the percent of EGFP-expression after cytoplasmic microinjection (E(cyt)) divided by that after nuclear microinjection (E(nuc)). Vertical bars indicate the standard deviation of triplicate experiments. The statistical differences were determined by one-way ANOVA followed by the Student–Newman–Keuls test. (*, p < 0.05).
Figure 3EGFP expression after the cytoplasmic and nuclear microinjection of naked DNA. One thousand copies and 10 copies of three types of DNAs (MC07.CMV-EGFP, pBS-EGFP and pcDNA3.1-EGFP) were injected into the cytoplasm (A) and nucleus (B) with 0.5% RhoDex. At 24 h post injection, the ratio of GFP-positive cells to RhoDex-positive cells was calculated. (C) NT scores were calculated as the percent of EGFP-expression after cytoplasmic microinjection (E(cyt)) divided by that after nuclear microinjection (E(nuc)). Vertical bars indicate the standard deviation of triplicate experiments. The statistical differences were determined by one-way ANOVA followed by the Student–Newman–Keuls test (*, p < 0.05).